PANCREATIC CYSTADENOMA

PANCREATIC CYSTADENOMA was reported 48 times

These drug classes are most commonly taken by patients reporting PANCREATIC CYSTADENOMA:

# Drug Count
0 Loop Diuretic [EPC] 13
1 Erythropoiesis-stimulating Agent [EPC] 11
2 alpha-Adrenergic Blocker [EPC] 11
3 beta-Adrenergic Blocker [EPC] 11
4 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 9
5 5-alpha Reductase Inhibitor [EPC] 7
6 Arteriolar Vasodilator [EPC] 7
7 Lipid-based Polyene Antifungal [EPC] 7
8 Polyene Antifungal [EPC] 7
9 Aldosterone Antagonist [EPC] 5
10 GLP-1 Receptor Agonist [EPC] 5
11 Aromatase Inhibitor [EPC] 4
12 Nonsteroidal Anti-inflammatory Drug [EPC] 4
13 Platelet Aggregation Inhibitor [EPC] 3
14 Aminosalicylate [EPC] 2
15 BCL-2 Inhibitor [EPC] 2
16 Corticosteroid [EPC] 2
17 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 2
18 Integrin Receptor Antagonist [EPC] 2
19 Proton Pump Inhibitor [EPC] 2
20 Tumor Necrosis Factor Blocker [EPC] 2
21 Anti-epileptic Agent [EPC] 1
22 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1
23 Aromatic Amino Acid [EPC] 1
24 Calcium [EPC] 1
25 Cannabinoid [EPC] 1
26 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 1
27 Cytochrome P450 3A Inhibitor [EPC] 1
28 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
29 Dihydropyridine Calcium Channel Blocker [EPC] 1
30 Ergot Derivative [EPC] 1
31 Expectorant [EPC] 1
32 Histamine-2 Receptor Antagonist [EPC] 1
33 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
34 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1
35 Interleukin-12 Antagonist [EPC] 1
36 Interleukin-23 Antagonist [EPC] 1
37 Janus Kinase Inhibitor [EPC] 1
38 Mood Stabilizer [EPC] 1
39 Phosphodiesterase 4 Inhibitor [EPC] 1
40 Protease Inhibitor [EPC] 1
41 Purine Antimetabolite [EPC] 1
42 Standardized Chemical Allergen [EPC] 1
43 Sulfonylurea [EPC] 1
44 Thiazide-like Diuretic [EPC] 1
45 Vitamin B12 [EPC] 1
46 Vitamin C [EPC] 1
47 Vitamin D [EPC] 1